ALBCURA CORPORATION
Update：2026/08/06
Industries
Main Industry
Biotechnology
Main Product/Service
Albcura’s flagship product line, deAlbumin™, is recombinant human serum albumin (rHSA) produced in yeast (e.g., Pichia pastoris), formulated with a well-defined recipe to eliminate plasma-derived impurities and ensure batch-to-batch consistency. This enab
Founded Year
2017
Unified Business No.
52534104
Status
Active
Number of Employees
0
Total Paid-in
Capital
189,952,920 (NT$)
Location of Company
Taiwan
, New Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Albcura Corporation, headquartered in Taiwan, is a biotechnology startup specializing in the development and production of high-quality, animal-component-free recombinant human serum albumin (rHSA). Their products are designed for applications in cell culture, pharmaceutical excipients, and bioprocessing. Operating under an ISO 13485 certified quality system, Albcura pursues scientific innovation to deliver consistent, reliable protein reagents for both research and clinical use.
